The following review evaluates the current data implicating a role for
hepatic iron in enhancing the liver injury in patients with chronic h
epatitis C infection. Iron removal lowers transaminases, but doesn't a
ppear to improve responsiveness to interferon-alpha therapy. An import
ant effect of iron removal might be to delay progression of liver inju
ry to fibrosis and cirrhosis. Until such a hypothesis is disproven, ph
lebotomy therapy for even mildly iron-loaded HCV patients is recommend
ed.